46 results on '"Alexis, Andrew"'
Search Results
2. Best practices in the treatment of melasma with a focus on patients with skin of color
3. Integrating skin color assessments into clinical practice and research: A review of current approaches
4. Treatment recommendations for acne-associated hyperpigmentation: Results of the Delphi consensus process and a literature review
5. A retrospective clinical and laboratory analysis including vitamin D and antinuclear antibodies in central centrifugal cicatricial alopecia and nonscarring alopecia in African Americans
6. Letter from the Journal: Improving diagnostic acumen and patient outcomes
7. TREATMENT RECOMMENDATIONS FOR ACNE-ASSOCIATED HYPERPIGMENTATION: RESULTS OF A DELPHI CONSENSUS PROCESS AND LITERATURE REVIEW
8. Unmet needs for patients with seborrheic dermatitis
9. Diversity, equity, and inclusion: The visionary future of JAAD
10. 32496 Efficacy and safety of abrocitinib according to geographies
11. Patient-reported outcomes with sarecycline treatment for acne vulgaris: Pooled analysis of phase 3 clinical studies
12. 51907 VISIBLE: Guselkumab Provides Significant Improvements in Health-related Quality of Life in Skin of Color Participants With Moderate-to-Severe Plaque Psoriasis
13. 52871 Tapinarof Cream 1% Once Daily is Efficacious for the Treatment of Moderate to Severe Atopic Dermatitis in Patients with Skin of Color Down to 2 Years of Age in Two Pivotal Phase 3 Trials
14. 52714 Racial/Ethnic Differences Among Atopic Dermatitis Patients Regarding the Perceived Impact of Disease, Satisfaction With Treatment, and Communication With Care Team
15. 54671 Prevalence of melasma, impact on quality of life and social stigmatization: results of the first large international survey
16. 54772 Pigmentary disorders, prevalence, impact on quality of life and social stigmatization: Results of the first large international survey
17. 51125 PATIENT EXIT INTERVIEWS ILLUSTRATE BENEFIT OF TRIFAROTENE ON ACNE-INDUCED PIGMENTARY PROBLEMS
18. 52946 Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Black Participants with Moderate-to-Severe Acne
19. 50532 VISIBLE: Guselkumab Demonstrated Significant Scalp Psoriasis Clearance and Scalp Itch Improvements at Week 16 in Skin of Color Participants With Moderate-to-Severe Plaque Psoriasis
20. 53113 Trifarotene shown to improve acne and related sequelae (scars, pigmentation)
21. 54728 Prevalence of post-inflammatory hyperpigmentation, impact on quality of life and social stigmatization: results of the first large international survey
22. 53447 Phase IV studies show trifarotene is efficacious and suitable for broad range of patient types
23. 53767 A practical algorithm for the integration of skincare to improve patient outcomes and satisfaction with energy-based dermatologic procedures
24. Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne
25. Misconceptions of photoprotection in skin of color
26. Photoprotection for skin of all color: Consensus and clinical guidance from an expert panel
27. Increasing racial and ethnic diversity in dermatology: A call to action
28. 25992 Long-term efficacy of tildrakizumab 100 mg by PASI 75/90/100 and PGA in a pooled analysis of reSURFACE 1 and reSURFACE 2 through up to 4 years of treatment
29. 44063 Short Term Efficacy and Racial and Ethnic Diversity in Risankizumab Phase 3 Clinical Trials for Treatment of Moderate-to-Severe Plaque Psoriasis
30. 43140 Impact of Sarecycline on Quality of Life in Skin of Color Patients with Acne Vulgaris: Post Hoc Analysis of Phase 3 Trials
31. 44248 Patient Reported Outcomes (PROs) assessed using Acne Symptom and Impact Scale (ASIS) among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S: Race stratified analysis of PROSES
32. 41942 Improving Acne Care Recommendations From Personalising Acne: Consensus Of Experts (PACE)
33. 44255 Impact of acne on social functioning, emotional functioning, and activities of daily living(ADL) among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S: Race stratified analysis
34. 43185 Efficacy of Sarecycline for Truncal Acne in Patients With Skin of Color: Post Hoc Analysis of Phase 3 Trials
35. 43102 Efficacy of Sarecycline for Facial Acne Vulgaris in Patients With Skin of Color: Post Hoc Analysis of Phase 3 Trials
36. 43770 An Investigation of Geographic Disparities in Health Equity in the Treatment of Psoriasis
37. 42193 Advancing Diversity in Dermatology Research: The VISIBLE Study Experience
38. 15354 Response to treatment with secukinumab in obese patients with moderate to severe psoriasis
39. 15340 Long-term treatment with secukinumab led to sustained clinical improvement and normalization of inflammatory markers in patients with psoriasis
40. Dispelling the myth: Perceptions of skin cancer susceptibility in Fitzpatrick types IV to VI: P7119
41. Acne vulgaris in adult females: Racial differences in clinical characteristics, perceptions, and behaviors relevant to facial acne: P6992
42. Effectiveness and safety of doxycycline 40 mg monotherapy for the treatment of rosacea in skin type subgroups
43. Alefacept in the treatment of psoriatic nail disease: A small case series
44. Etanercept does not effectively treat moderate to severe alopecia areata: An open-label study
45. Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: Review and clinical practice experience
46. A. Paul Kelly, MD (1938-2014): The “quiet pioneer” in dermatology for skin of color
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.